Iterum Therapeutics plc Analysis
| Analyst Ratings |
|
Average Target Price
|
1.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-1.27
|
0.00
|
1.27
|
100.00%
|
|
2022-12-31
|
-1.22
|
0.00
|
1.22
|
100.00%
|
|
2022-09-30
|
-1.05
|
-0.97
|
0.08
|
7.62%
|
|
2022-06-30
|
-1.05
|
-0.60
|
0.45
|
42.86%
|
|
2022-03-31
|
-0.75
|
-0.30
|
0.45
|
60.00%
|
|
2021-12-31
|
-0.60
|
-0.30
|
0.30
|
50.00%
|
|
2021-09-30
|
1.80
|
0.30
|
-1.50
|
-83.33%
|
|
2021-06-30
|
-0.97
|
0.60
|
1.57
|
161.86%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.87
|
|
2021-12-31
|
-11.55
|
|
2020-12-31
|
-14.93
|
|
2019-12-31
|
-7.11
|
|
2018-12-31
|
-6.15
|
|
2017-12-31
|
0.02
|